CoChat

Clinical inertia in the management of Type 2 diabetes metabolic risk factors

Grant, R. W., Cagliero, E., Dubey, A. K., Gildesgame, C., Chueh, H. C., Barry, M. J., Singer, D. E., Nathan, D. M., Meigs, J. B. · 2004 · Diabetic Medicine
Cited by 153

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Aims Delays in the initiation and intensification of medical therapy may be one reason patients with diabetes do not reach evidence‐based goals for metabolic control. We assessed intensification of medical therapy over time, comparing the management of hyperglycaemia, hypertension, and hyperlipidaemia. Methods Prospective cohort study of 598 adults with Type 2 diabetes receiving primary care in an academic medical centre from May 1997 to April 1999. We assessed whether patients failing to achieve standard treatment goals for haemoglobin A 1c (HbA 1c), systolic blood pressure (SBP), or low density lipoprotein (LDL) cholesterol when last measured during 12 months (Year 1, 5/97–4/98) had increases in their corresponding medical regimen during the following 12 months (Year 2, 5/98–4/99). Results Among untreated patients in Year 1, seven of 12 (58%) of those above goal for HbA 1c were initiated on medical therapy in Year 2, compared with 16 of 48 (34%) above SBP goal (P = 0.02) and 26 of 115 (23%) above LDL cholesterol goal (P = 0.02). Among patients on therapy and above goal, 124 of 244 (51%) patients with elevated HbA 1c had their regimen increased in Year 2, compared with 85 of 282 (30%) with elevated SBP (P < 0.001) and 22 of 79 (30%) with elevated LDL cholesterol (P < 0.001). From Year 1 to Year 2 there was a decline in the overall proportion of patients above goal for LDL cholesterol (from 58% to 45%, P = 0.002) but not for HbA 1c or blood pressure. Conclusions Greater initiation and intensification of pharmaceutical therapy, particularly for elevated blood pressure or cholesterol, may represent a specific opportunity to improve metabolic control in Type 2 diabetes. Diabet. Med. 21, 150–155 (2004)

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-5491.2004.01095.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 153

Metadata

Authors
Grant, R. W., Cagliero, E., Dubey, A. K., Gildesgame, C., Chueh, H. C., Barry, M. J., Singer, D. E., Nathan, D. M., & Meigs, J. B.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2004-01-30
Volume
21
Issue
2
Pages
150-155
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W2055938623
Cited by
153
References
6
FWCI
8.01
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical inertia in the management of Type 2 diabetes metabolic risk factors. https://app.cochat.ai/papers/10.1111/j.1464-5491.2004.01095.x
The paper
Grant, R. W., Cagliero, E., Dubey, A. K., Gildesgame, C., Chueh, H. C., Barry, M. J., Singer, D. E., Nathan, D. M., & Meigs, J. B. (2004). Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabetic Medicine. https://doi.org/10.1111/j.1464-5491.2004.01095.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.